|
1
|
Zhou JH, Zhu XL, Li MY, Luo YW, Yang ZM, Wang L, Tong T, Qin SL, Liu BL, Chen BH, Hu W. Local adrenomedullin gene delivery inhibits Leydig cell dysfunction by rescuing steroidogenic enzymes in vivo. Andrologia 2022; 54:e14545. [PMID: 35942817 DOI: 10.1111/and.14545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 07/12/2022] [Accepted: 07/19/2022] [Indexed: 11/29/2022] Open
Abstract
Adrenomedullin (ADM) has beneficial effects on Leydig cells under pathological conditions, including lipopolysaccharide (LPS)-induced orchitis. Our previous studies demonstrated that ADM exerts a restorative effect on steroidogenesis in LPS-treated primary rat Leydig cells by attenuating oxidative stress, inflammation and apoptosis. In this study, we aim to investigate whether ADM inhibits Leydig cell dysfunction by rescuing steroidogenic enzymes in vivo. Rats were administered with LPS and injected with Ad-ADM, an adeno-associated virus vector that expressed ADM. Then, rat testes were collected for 3β-hydroxysteroid dehydrogenase (3β-HSD) immunofluorescence staining. Steroidogenic enzymes or steroidogenic regulatory factors or protein, including steroidogenic factor-1 (SF-1), liver receptor homologue-1 (LRH1), Nur77, steroidogenic acute regulatory protein (StAR), cytochrome P450 cholesterol side chain cleavage enzyme (P450scc), 3β-HSD, cytochrome P450 17α-hydroxylase/17, 20 lyase (CYP17) and 17β-hydroxysteroid dehydrogenase (17β-HSD), were detected via gene expression profiling and western blot analysis. Plasma testosterone concentrations were measured. Results showed that ADM may inhibit Leydig cell dysfunction by rescuing steroidogenic enzymes and steroidogenic regulatory factors in vivo. The reduction in the number of Leydig cells after LPS exposure was reversed by ADM. ADM rescued the gene or protein levels of SF-1, LRH1, Nur77, StAR, P450scc, 3β-HSD, CYP17 and 17β-HSD and plasma testosterone concentrations. To summarize ADM could rescue some important steroidogenic enzymes, steroidogenic regulatory factors and testosterone production in Leydig cells in vivo.
Collapse
Affiliation(s)
- Jian-Hua Zhou
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Xia-Lian Zhu
- Department of Nuclear Medicine, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Ming-Yong Li
- Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - You-Wen Luo
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Zhi-Min Yang
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Li Wang
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Tao Tong
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Song-Lin Qin
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Bo-Long Liu
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| | - Bing-Hai Chen
- Department of Urology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
| | - Wei Hu
- Department of Andrology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China
| |
Collapse
|